Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
12.05.25
/
50%
€1.63
Target price
12.05.26
€3.56
Performance (%)
46.65%
Price
23.12.25
€2.40
Summary
This prediction is currently active. With a performance of 46.65% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 12.05.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 14.395% | 14.395% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.40
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
-
23.12.25
23.12.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
-20.11%
23.12.25
23.12.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25